The North America Nephrostomy Devices Market would witness market growth of 7.5% CAGR during the forecast period (2019-2025). Due to favorable reimbursement policies, increased product awareness, the accessibility of highly skilled physicians and the involvement of well-established healthcare facilities in the region, it is expected to see significant growth in the future as well. Also, it is expected that the rapid adoption of technologically advanced medical products will drive the region’s market. Increasing government funding for R&D activities in surgical devices as well as procedures also have a positive impact on regional market growth.
Over the past few years, percutaneous nephrostomy (PCN) processes have become immensely popular as they eliminate the need for nephrostomy tube or ureteral stent devices. The PCN procedure delivers various benefits, including minimal blood loss; low treatment costs, and prevents leakage of urine. These processes minimize stay in the hospital, create smaller incisions, and guarantee a quicker recovery. As a result, the increasing popularity of percutaneous nephrostomy (PCN) processes during the forecast period will boost the demand for nephrostomy machines.
Based on Product, the market is segmented into Guidewires, Sheath Dilators, Nephrostomy Catheters, Drainage Tubes and Other Nephrostomy Devices. Based on End Use, the market is segmented into Hospital, Ambulatory Surgical Centers (ASCs) and Emergency Clinics. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Teleflex, Inc., Cook Medical, Inc. (Cook Group), Coloplast Group, Olympus Corporation, Argon Medical Devices, Inc., UreSil LLC, B. Braun Melsungen AG, Cardinal Health, Inc., and Becton, Dickinson and Company.
Scope of the Study
• Sheath Dilators
• Nephrostomy Catheters
• Drainage Tubes
• Other Nephrostomy Devices
By End Use
• Ambulatory Surgical Centers (ASCs)
• Emergency Clinics
• Rest of North America
• Boston Scientific Corporation
• Teleflex, Inc.
• Cook Medical, Inc. (Cook Group)
• Coloplast Group
• Olympus Corporation
• Argon Medical Devices, Inc.
• UreSil LLC
• B. Braun Melsungen AG
• Cardinal Health, Inc.
• Becton, Dickinson and Company
Unique Offerings from KBV Research
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free
Our reports have been used by over 10K customers, including:
The Global Urology Laser Market size is expected to reach $1.3 billion by 2025, rising at a market growth of 5.7% CAGR during the forecast period. Urology laser surgical equipment is used for incision and resection of soft tissue and tumor ablation. Laser therapy is a medical treatment that utilizes a strong light beam to cut, burn, or destroy...
The Japan urology ultrasound equipment market is expected to reach US$ 39.22 Mn in 2027 from US$ 21.16 Mn in 2018. The market is projected to grow with a CAGR of 7.2% from 2019-2027. The growth of the urology ultrasound equipment market is attributed to the increasing urological disorders in the elderly population and the growing medical...
Male Infertility - Pipeline Review, H2 2019 Summary The latest Pharmaceutical and Healthcare disease pipeline guide Male Infertility - Pipeline Review, H2 2019, provides an overview of the Male Infertility (Male Health) pipeline landscape. Male infertility refers to a male’s inability to achieve...
The Global Nephrostomy Devices Market size is expected to reach $1.5 billion by 2025, rising at a market growth of 8% CAGR during the forecast period. The growing popularity of percutaneous nephrostomy processes is a key factor in creating potential growth opportunities for the nephrostomy device industry. Several complications are required...
"Cystitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Cystitis. The marketed products information covers their product details, patents (US & EU), historical and forecasted sales till 2023. It further provides the marketed products API...
C5a Anaphylatoxin Chemotactic Receptor 1 - Pipeline Review, H2 2019 Summary C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Complement component 5a receptor 1 (C5AR1) or CD88 is a G protein-coupled receptor for C5a. It functions as a complement receptor. Receptor activation stimulates...
The North America Urology Laser Market would witness market growth of 4.93% CAGR during the forecast period (2019-2025). Technological advances in urology laser equipment play a vital role in stimulating the market for laser urology. For example, urology device Lumenis provides MOSES technology that delivers technologically advanced...
The Asia Pacific Urology Laser Market would witness market growth of 7.27% CAGR during the forecast period (2019-2025). The laser portfolio and its use in urological applications have been extended by technological developments in lasers and minimally invasive surgeries. In fact, increased access to these resources around the globe...
The Europe Urology Laser Market would witness market growth of 5.09% CAGR during the forecast period (2019-2025). In the contemporary medical landscape, laser technology has become a standard treatment for several diseases. In particular, laser treatment in various urological disorders is considered the standard of care. Although initially...
The Latin America, Middle East and Africa Urology Laser Market would witness market growth of 7.25% CAGR during the forecast period (2019-2025). The use of lasers in the treatment of urolithiasis, urinary strictures, and bladder tumors has made it safe to treat older patients with several comorbidities without further need to change...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.